WP Thyroid recalled over manufacturing violations
- Recall date
- August 25, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5750-2 ; b) 30 Tablets…
- Recall number
- D-1609-2020
- FDA classification
- Class II
- Brand / firm
- RLC Labs Inc.
- Sold / distributed
- Nationwide in the United States
Why it was recalled
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5750-2 ; b) 30 Tablets, NDC 64727-5750-4; c) 60 Tablets, NDC 64727-5750-5; d) 90 Tablets, NDC 64727-5750-6; e) 100 Tablets, NDC 64727-5750-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034
Get recall alerts
Free email alert whenever RLC Labs Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RLC Labs Inc.